Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples